Glenn F. Pierce
Director/Board Member en VOYAGER THERAPEUTICS, INC. .
Fortuna: 181 276 $ al 29/02/2024
Perfil
Presently, Glenn F.
Pierce is Chief Medical Officer & Senior Vice President at Bioverativ Therapeutics, Inc. Dr. Pierce is also on the board of World Federation of Hemophilia and Voyager Therapeutics, Inc. and Member of American Society of Hematology, Member of The International Society On Thrombosis & Haemostasis and Member of Hemostasis & Thrombosis Research Society.
He previously held the position of Chief Medical Officer & SVP-Global Medical Affairs at Biogen, Inc., Chief Medical Officer of Ambys Medicines, Inc., Principal at Amgen, Inc., Vice President-Therapeutic Product Development at Selective Genetics, Inc. and Vice President-PreClinical Development at Prizm Pharmaceuticals, Inc. (a subsidiary of Selective Genetics, Inc.), Vice President-Research & Clinical Development at Avigen, Inc., Vice President-Applied Research Hematology at Bayer Healthcare LLC and President for National Hemophilia Foundation.
He received a doctorate and an undergraduate degree from Case Western Reserve University and a graduate degree from Washington University in St. Louis.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
06/06/2023 | 21 788 ( 0.05% ) | 181 276 $ | 29/02/2024 |
Cargos activos de Glenn F. Pierce
Empresas | Cargo | Inicio |
---|---|---|
VOYAGER THERAPEUTICS, INC. | Director/Board Member | 05/01/2017 |
Hemostasis & Thrombosis Research Society | Corporate Officer/Principal | - |
World Federation of Hemophilia | Director/Board Member | 01/01/2015 |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Corporate Officer/Principal | - |
The International Society On Thrombosis & Haemostasis | Corporate Officer/Principal | - |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 25/01/2011 |
Antiguos cargos conocidos de Glenn F. Pierce.
Empresas | Cargo | Fin |
---|---|---|
GLOBAL BLOOD THERAPEUTICS, INC. | Director/Board Member | 05/10/2022 |
Ambys Medicines, Inc.
Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Ambys Medicines, Inc. develops regenerative medicine therapies for serious liver diseases. The company was founded by Martin Burke, Markus Grompe, Juan Carlos Izpisua Belmonte and Holger Willenbring and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01/08/2020 |
BIOGEN INC. | Chief Tech/Sci/R&D Officer | 01/05/2014 |
░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formación de Glenn F. Pierce.
Washington University in St. Louis | Graduate Degree |
Case Western Reserve University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
AMGEN INC. | Health Technology |
BIOGEN INC. | Health Technology |
VOYAGER THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 12 |
---|---|
Avigen, Inc.
Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Health Technology |
Bayer Healthcare LLC
Bayer Healthcare LLC Pharmaceuticals: MajorHealth Technology Bayer Healthcare LLC provides healthcare and pharmaceutical medicines. It also provides researching, developing, manufacturing and marketing services for the prevention, diagnosis and treatment of diseases. The company is headquartered in Whippany, NJ. | Health Technology |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Health Technology |
World Federation of Hemophilia | |
Prizm Pharmaceuticals, Inc. | Health Technology |
Selective Genetics, Inc.
Selective Genetics, Inc. Medical SpecialtiesHealth Technology Selective Genetics, Inc. developed gene therapeutics and DNA devices for tissue repair and regeneration. The company was founded by Thomas S. Porter in 1998 and was headquartered Encinitas, CA. | Health Technology |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Commercial Services |
National Hemophilia Foundation | |
The International Society On Thrombosis & Haemostasis | |
Hemostasis & Thrombosis Research Society | |
Ambys Medicines, Inc.
Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Ambys Medicines, Inc. develops regenerative medicine therapies for serious liver diseases. The company was founded by Martin Burke, Markus Grompe, Juan Carlos Izpisua Belmonte and Holger Willenbring and is headquartered in South San Francisco, CA. | Health Technology |
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |